Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 28, 2022

Study Completion Date

April 17, 2024

Conditions
Atrial FibrillationPersistent or Longstanding Persistent Atrial Fibrillation
Interventions
DEVICE

AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation

Trial Locations (17)

17104

Pinnacle Health, Harrisburg

23298

Virginia Commonwealth University, Richmond

23507

Sentara Cardiovascular Research Institute, Norfolk

32610

Shands at the University of Florida, Gainesville

32806

Orlando Heart Institute, Orlando

34239

Sarasota Memorial Hospital, Sarasota

45219

The Christ Hospital, Cincinnati

54401

Aspirus Research Institute, Wausau

83706

Saint Alphonsus Regional Medical Center, Boise

90048

Cedars-Sinai Heart Institute, Los Angeles

90806

Long Beach Memorial Medical Center, Long Beach

94305

Stanford University Department of CV medicine, Stanford

94574

St. Helena Hospital, Adventist Heart Institute, St. Helena

94609

Alta Bates Sutter Medical Center, East Bay Hospital, Oakland

Unknown

Tri Health Hosptial - Good Samaritan and Bethesda North Hospitals, Cincinnati

Universitair Ziekenhuis Brussel (UZ Brussels), Brussels

Academic Medical Center (AMC), Amsterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT02393885 - Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) Approach | Biotech Hunter | Biotech Hunter